Minister of Health Ginette Petitpas Taylor announces intent to severely restrict marketing of opioids
"High rates of opioid prescriptions are a contributing factor to Canada's opioid crisis. As Minister, I am calling on industry to act now and stop their marketing activities associated with these products in Canada. I have asked my Department to assess evidence of the benefits and harms of past and current opioid marketing practices. This evidence will inform our plans to severely restrict most forms of opioid marketing through regulation. These measures, along with new funding announced today, will help us to better protect Canadians and to support those dealing with problematic substance use."
The Honourable Ginette Petitpas Taylor
Minister of Health
"I am deeply concerned by the opioid crisis in Canada. In 2017, we saw an increase of 34% of apparent opioid-related deaths across Canada when compared to 2016.. This is unlike any other public health crisis we have experienced in recent years. It is crucial to deal with both the immediate crisis and the root causes that lead people to problematic substance use, so that solutions will save lives and reverse the trend on this national health crisis."
Dr. Theresa Tam
Chief Public Health Officer of Canada
These measures are in addition to Regulations published on May 2, 2018 in Canada Gazette, Part II that allow the Minister of Health to require companies to develop and implement risk management plans. This requirement includes preclearance of opioid-related materials provided to health care professionals to ensure advertising materials comply with the terms of market authorization.
The Substance Use and Addictions Program is a federal contributions program that provides financial support to project proponents from the provinces, territories, non-governmental organizations and key stakeholders to strengthen responses to drug and substance use issues in Canada. The projects announced today include surveillance initiatives, education and training for peers and peer workers, and projects to develop best practices for medication-assisted treatments.
Through the Canadian Institutes of Health Research, the Government is funding scientists who are working to provide evidence of the best interventions to treat pain, prevent opioid overdoses, treat opioid use disorder and promote harm reduction.
Office of Ginette Petitpas Taylor
Minister of Health
Health Canada and the Public Health Agency of Canada
Report a problem or mistake on this page
- Date modified: